Alternative splicing of the host defense gene MxA during HSV-1 infection produces a novel isoform that supports rather than restricts viral replication.
No takes yet. Share an insight, caveat, or question.
Highlights potential viral hijacking of host splicing machinery; leaves open MxA isoform targeting as antiviral strategy pending human validation.
Ku et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: